Radiation therapy for prostate cancer that has spread to few areas
Part of Cancer, Kidney & urinary clinical trials.
This trial tests whether radiation therapy can help treat prostate cancer that has spread to only a few places in the body (oligometastatic). It aims to see if targeting both the prostate and the small number of metastases can improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- A biopsy has confirmed prostate cancer.
- You have up to 3 areas where the cancer has spread (not in organs like the liver or lungs).
- You have not had previous treatment for prostate cancer, such as radiation, chemotherapy, or surgery to remove the tumor.
- Your doctor expects you to live longer than 2 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of surgery and radiation to remove as much cancer as possible in men with prostate cancer that has spread to a few spots outside the prostate. It aims to see if this aggressive approach can improve long-term outcomes.
This trial tests a new approach using radiation therapy (radiotherapy) combined with hormone therapy before the standard surgery to remove the prostate. It aims to see if this combination can better control prostate cancer that has spread to a few spots (oligometastatic) and improve outcomes.
This trial studies the use of radiation to the prostate and to all visible spots where cancer has spread, in men who have up to 10 small areas of spread when first diagnosed. The goal is to see if this approach can help control the cancer.
This trial tests whether giving intense hormone therapy along with either radiation or surgery can help men with prostate cancer that has spread to a limited number of spots (10 or fewer) but not to organs like the liver or lungs. The goal is to treat both the main tumor and the visible metastatic spots more aggressively.
This trial studies whether adding focused radiation (SBRT) to hormone therapy can control prostate cancer that has spread to only a few places. It aims to help people with early “oligometastatic” prostate cancer by improving disease control while limiting treatment side effects.
This trial is testing whether giving radiation to all spots of cancer that show up on a PSMA PET scan works better than giving radiation only to the main tumor in the prostate. It is for men whose prostate cancer has spread to a few other places (up to 10 spots).
Hear when a new Oligo-metastatic Prostate Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.